Kestra Medical Technologies (KMTS) Enterprise Value (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Enterprise Value data on file, last reported at -$358.9 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 51.07% year-over-year to -$358.9 million in Q2 2026; TTM through Apr 2026 was -$358.9 million, a 51.07% decrease from a year earlier, with the FY2026 full-year figure at -$358.9 million, down 51.07% from the prior year.
• Enterprise Value for Q2 2026 stood at -$358.9 million, down from -$291.3 million in the prior quarter.
• Over the last five years, Enterprise Value for KMTS reached as high as -$8.2 million in Q2 2024 and fell as low as -$358.9 million in Q2 2026.
• Historically, Enterprise Value has averaged -$150.3 million across 3 years, with a median of -$137.7 million in 2024.
• Across the five-year window, Enterprise Value slumped 2780.29% in 2025 and tumbled 51.07% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$76.9 million in 2024, then tumbled by 128.07% to -$175.4 million in 2025, then sank by 104.6% to -$358.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$358.9 million in Q2 2026, -$291.3 million in Q1 2026, and -$175.4 million in Q4 2025.